TORONTO, Sept. 5, 2017 /PRNewswire/ -- Recent research published suggests that reducing physical stress can significantly improve diabetes and diabetic neuropathy. The study, published in Medical Acupuncture, used sophisticated Electrocardiogram (ECG) to measure internal stress levels pre and post Microcurrent Point Stimulation (MPS) applied to a simple acupuncture protocol called Battlefield Acupuncture.
In this study, MPS was reported to produce significant positive stress changes throughout the patient sample, reducing stress 27%, which improved the key scientific diabetes and diabetic neuropathy marker Photoplethysmography very low frequency index or PTGVLFi an astounding 36% after a single application. PTGVLFi is an Autonomic Nervous System regulation marker of endothelial function and an indicator of beta cell activity (Endothelial dysfunction can contribute to several disease processes such as hypertension, hypercholesterolaemia, diabetes, septic shock, and can lead towards coronary artery disease). Beta cells are insulin producing cells located in the pancreas, and this is a marker for glucose intolerance (diabetes) and microcirculation complications (diabetic neuropathy). Previous research studies show patients with high PTGVLFi numbers are at risk for diabetes.
The implication that clinicians or patients may apply this non-invasive therapy to control diabetes is medially significant. MPS therapy is applied using Dolphin Neurostim devices that are FDA cleared for the treatment of chronic pain & stress. MPS is non-invasive, and produces immediate and measurable physical stress reduction and increased blood flow to the feet after application.
To find out more on MPS for diabetes or diabetic neuropathy please contact Center for Pain & Stress Research: [email protected] or 1-800-567-PAIN. Visit www.dolphinmps.com for device information.
Media Contact: Ron Barranger, (416) 253-6060, [email protected]
SOURCE Center for Pain & Stress Research
Share this article